Kardiorespirator tadqiqotlar jurnali 2. 2021.pdf
Subject of the article
COVID-19 YURAK QON TOMIR KASALLIKLARI BOR BEMORLARDA KECHISHI (47-50)
Authors
Tog'ayeva B.M., Tashkenbayeva E.N., Abdiyeva G.A., Xaydarova D.D., Abdullayeva Z.A.
Institution
Samarqand davlat tibbiyot instituti
Abstract
COVID-19 va yurak-qon tomir kasalliklari keng tarqalgan. Bu kasalliklar birgalikda kelishi salbiy oqibatlar xavfini oshiradi. Ta'minlash bunday bemorlar shifokorlardan virusli infeksiyaning xususiyatlarini, uning klinikasini bilishni talab qiladi, yurak-qon tomir kasalliklari bilan birlashganda yuzaga keladigan hodisalar, shuningdek individual choralar va jamoaviy himoya. Tibbiy xodimlarning xavfsizligi va bemorlar uchun yaxshi prognoz zamonaviy sog'liqni saqlash tizimining eng yuqori qadriyatlaridan biridir.
Key words
Yurak-qon tomir kasalliklari, yurak yetishmovchiligi, prognoz, dori terapiyasi
Literature
1. Guan W.J., Ni Z.Y., Hu Y., Liang W., Ou Ch., He J. et al.Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 2020 Feb 28. doi: 10.1056/NEJMoa2002032. 2. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-24 February 2020. Available at: https://wwwwhoint/docs/default- source/coronaviruse/who-chinajoint-mission-on-covid-19-final-reportpdf. (accessed March 9, 2020. 3. Шляхто Е. В., Конради А. О., Арутюнов Г. П., Арутюнов А. Г., Баутин А. Е., Бойцов С. А., Виллевальде С. В., Григо-рьева Н. Ю., Дупляков Д. В., Звартау Н. Э., Козиолова Н. А., Лебедев Д. С., Мальчикова С. В., Медведева Е. А., Михайлов Е. Н., Моисеева О. М., Орлова Я. А., Павлова Т. В., Певзнер Д. В., Петрова М. М., Ребров А. П., Ситникова М. Ю., Соло-вьева А. Е., Тарловская Е. И., Трукшина М. А., Федотов П. А.,Фомин И. В., Хрипун А. В., Чесникова А. И., Шапошник И.И., Явелов И. С., Яковлев А. Н. Руководство по диагностикеи лечению болезней системы кровообращения в контексте пандемии COVID-19. Российский кардиологический журнал.2020;25(3):3801. doi:10.15829/1560 4071-2020-3-3801. 4. Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J.,Bondi-Zoccai G. et al Cardiovascular Considerations for Patients,Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol. 2020 Mar 19. Epublished Doi:10.1016/j.jacc.2020.03.031. 5. Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z.,Zhao Yu. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 Mar 11; 1-8 doi: 10.1007/s00392-020-01626-9 6. Wu Z., Mc Googan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. Feb 24. doi: 10.1001/jama.2020.2648. 7. Porcheddu R., Serra C., Kelvin D., Kelvin N., Rubino S.Similarity in Case Fatality Rates (CFR) of COVID-19/SARSCOV-2 in Italy and China. J Infect Dev Ctries. 2020;14:125-128. doi: 10.3855/jidc.12600 8. Chen N., Zhou M., Dong X., Qu J., Gong F., Ya. Han et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020;395:507-513. doi: 10.1016/S0140-6736(20)30211-7. 9. Liu W.M., Vander Zeijst B.A., Boog C.J., Soethout E.C.Aging and impaired immunity to influenza viruses: implications for vaccine development. HumVaccin. 2011; 7 Suppl: 94-8. 10.Мухиддинов А.И.,Ташкенбаева Э.Н.,Хайдарова Д.Д.,Абдиева Г.А.,Тогаева Б.М. Клиникая характерестика прогрессирования артериальной гипертонии с риском сердечно сосудистных осложнений при СOVID-19. Polish Sience Journal.Issue 1(34) Warsaw.2021y/ Р.220-226. 11. Saltiel A.R., Olefsky J.M. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127:1-4 12. Akhmerov A., Marban E. COVID-19 and the Heart.Circulation. 2020 Apr 11. doi: 10.1161/CIRCRESAHA.120.317055. 13. Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasonit D. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;DOI: 10.1001/jamacardio.2020.1096.14. ZhengY.-Y., MaY.-T., Zhang J.-Y., Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology.2020. Mar 5. doi: 10.1038/s41569-020-0360-5. 15. Khasanjanova F.O.,Khaydarova D.D., Togayeva B.M., To study the frequency of the risk factors of smoking in pstients with acute coronary syndrome in young age.Science, Research, Development #33. Paris 29-30. 09. 2020 y/ P. 78-80 16. Mortality G.B.D., Causes of Death C. Global, regional,and national life expectancy, all-cause mortality, and causespecific mortality for 249 causes of death, 1980-2015: asystematic analysis for the Global Burden of Disease Study 2015Lancet. 2016;388:1459-1544. 17. Liang W., Guan W., Chen Retal. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335-337. 18. Guo T., FanY., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMACardiol. 2020 Mar 27. doi: 10.1001/jamacardio.2020.1017. 19. Sharon E. Fox, Aibek Akmatbekov, Jack L. Harbert,Guang Li, J. Quincy Brown, Richard S. Vander Heide. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. medRxiv. https://www.medrxiv.org/content/10.1101/2020.04.06.20050575v1/doi:https://doi.org/10.1101/2020.04.06.20050575. 20. Welt F.G.P., Shah P.B., Aronow H.D., Bortnick A.E.,Henry T.D., Sherwood M.W., Young M.N., Davidson L.J.,Kadavath S., Mahmud E., Kirtane A.J., American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI), Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020 Mar 16; S0735-1097(20)34566-6. doi: 10.1016/j.jacc.2020.03.021. 21. Bettari L., Pero G., Maiandi C., Messina A., Saccocci M.,Cirillo M., Troise G., Conti E., Cuccia C., Maffeo D. Exploring personal protection during high-risk PCI ina COVID-19 patient Impella CP mechanicalsupportduring ULMCA bifurcationstenting.JACC: CaseReports. Apri2020DOI:10.1016/j.jaccas.2020.03.006. 22. Fried J.A., Ramasubbu K., Bhatt R., Topkara V.K.,Clerkin K.J., Horn E. et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation. 2020 Apr 3. doi:10.1161/CIRCULATIONAHA.120.047164. 23. Juneman E. Leading the compassionate charge.Circ Heart Fail. 2020 Apr;13(4):e007085. doi: 10.1161/CIRCHEARTFAILURE.120.007085. 24. Oudit G.Y., Kassiri Z., Jiang C., Liu P.P., Poutanen S.M.,Penninger J.M., Butany J. SARS-coronavirus Modulation of Myocardial ACE2 Expression and Inflammation in PatientsWith SARS Eur J Clin Invest. 2009 Jul; 39(7):618-25. doi:10.1111/j.1365-2362.2009.02153.x